Pyridostigmine reverses paediatric complications of botulinum toxin therapy
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
List view / Grid view
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera...
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
Children with an extremely deadly form of brain cancer may benefit from a new treatment that aims to direct an immune response against an abnormally shaped protein found on cancer cells...
Technical leadership in contract development and manufacturing...
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory diseases...
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza...
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
Scientists are developing a vaccine by targeting strains of S. pneumoniae...